Diversified Consumer Services
Company Overview of Medical College Of Wisconsin
Medical College of Wisconsin is an educational institution offering biomedical education, patient care, and research facilities. It includes bioinformatics research center, biophysics research institute, biostatistics consulting center, cancer center, cardiovascular center, adenoviral core facility, center for aids intervention research, and center for the study of bioethics. The college was established in 1893 and is based in Milwaukee, Wisconsin. It has endowment assets worth $58.2 million.
8701 Watertown Plank Road
Milwaukee, WI 53226-0509
Founded in 1893
Key Executives for Medical College Of Wisconsin
President Emeritus and Trustee
Dean Emeritus and Director of Translational Research Resources Office
Vice President of Operations
Vice Chair of the Anesthesiology Department
Compensation as of Fiscal Year 2016.
Medical College Of Wisconsin Key Developments
Applied Genetic Technologies Corporation and Medical College of Wisconsin Announce Publication of Natural History Study Data Evaluating Residual Photoreceptor Cone Status in Patients with CNGB3-associated Achromatopsia
Aug 2 16
Applied Genetic Technologies Corporation and the Medical College of Wisconsin announced the publication of data from studies evaluating the density of cone photoreceptors in patients with CNGB3-associated achromatopsia (ACHM). The peer-reviewed study results appear in the current issue of Investigative Ophthalmology and Visual Science. Previous studies of gene-based therapies in animal models of ACHM have shown that the presence of viable cone photoreceptors is required for restoration of cone function. The current multi-center natural history study, conducted by researchers at MCW, the University of Alexandria in Egypt, Oregon Health & Science University, The Chicago Lighthouse, the University of Miami and the University of Florida, was designed to evaluate residual cone structures in patients with ACHM resulting from CNGB3 mutations. AGTC's clinical program for achromatopsia caused by mutations in the CNGB3 gene continues enrollment, and the company is on track to release interim data in 2016. Researchers used high-resolution imaging (optical coherence tomography [OCT]) and adaptive optics scanning light ophthalmoscopy (AOSLO) at MCW to evaluate peak cone density, inter-cone spacing, foveal outer nuclear layer thickness and photoreceptor layer integrity in 51 patients with CNGB3-associated ACHM. Analyzable images were obtained in 26 of the 51 patients, with nystagmus (repetitive uncontrolled eye movement) the major obstacle to obtaining high-quality images in the remaining subjects. Peak foveal cone density ranged from 7,273 to 53,554 cones/mm2, which is significantly lower than normal (ranging from 84,733 to 234,391 cones/mm2). Results also show that these cones may occur contiguously or be sparsely arranged within the fovea. Cones were less evenly spaced and generally sparser in patients in the ACHM group compared with six normal subjects. The data also show that the ACHM patients had significantly thinner outer nuclear layers (ONL) compared with previously reported normal values (p <0.0001). Statistical analyses of OCT measurements, a method for examining retinal structure in vivo, found significant differences in peak cone density when comparing OCT grade I to grade II (p = 0.0143) and grade I to grade IV (p = 0.0022). Differences in ONL thickness as a function of OCT grade were also observed between grade I and II (p = 0.0289) and grade I and IV (p = 0.0096). Consistent with suggestions that ACHM is a progressive disease, a significant association was observed between age and OCT grade, with grades II, IV and V differing from grade I (p=0.018, 0.0155, and 0.0205, respectively). Grade III results not included in these analyses due to sample size restrictions. Study researchers concluded that residual foveal cone structure varies greatly among patients with CNGB3-associated ACHM. Additionally, the use of split-detection AOSLO, which allows noninvasive imaging of rods and cones with cellular resolution, may be an important tool for evaluating residual cone structure in patients with ACHM and other retinal diseases. The authors noted that cellular resolution imaging will become an important tool for patient selection, monitoring and evaluation in future clinical trials.
Medical College of Wisconsin Appoints Richard Katschke as Chief Historian and Senior Associate Vice President for Communications
Mar 15 16
Richard Katschke has been appointed as Chief Historian and Senior Associate Vice President for Communications for the Medical College of Wisconsin. Katschke served as Associate Vice President of Public Affairs since 2002 after joining MCW in 1985 as Director of Public Affairs. He currently holds the distinction of being the longest-tenured public information officer among US medical schools.
Medical College of Wisconsin Appoints Christopher P. Kops as Senior Vice President for Finance and Administration and Chief Operating Officer, Effective February 15, 2016
Jan 25 16
Christopher P. Kops, CPA, MBA, has been named senior vice president for finance and administration and chief operating officer for the Medical College of Wisconsin (MCW). Kops currently serves as vice president and associate dean for administration and finance in the University of Chicagos Division of Biological Sciences. In his new role, Kops will serve as the principal administrative officer of MCW and a member of the institutions senior leadership team. He will be responsible for MCWs financial functions as well as the planning, organizing, evaluating and monitoring of all administrative and facilities functions. In addition, Kops will oversee strategic financial and administrative planning, budget development and implementation, policy formulation and organizational development. He will have oversight of human resources, faculty affairs, facilities, central purchasing, information services and other institutional functions as required to support MCWs missions. Kops has 25 years of experience in financial and administrative management, strategic planning, process improvement, faculty recruitment, and program development, as well as proven expertise in providing leadership and direction with demonstrated success in motivating and managing people. He joined the University of Chicago in 2011 and was a member of the cabinet of the executive vice president of health affairs/dean, and played a leadership role in strategic planning, policy development, issues management and executive problem-solving. From 2004 to 2011, Kops served as vice dean for administration and finance at the University of Pennsylvania School of Medicine (UPSOM) where he was a key advisor to the executive vice president/dean in all areas involving the School of Medicine administration and finance, was the chief operating officer, and represented the dean in business and financial matters within the medical school, with university officers and trustees, and with management and directors at the teaching hospitals. His new position is effective February 15, 2016.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|